This contract opportunity involves establishing a non-exclusive discount agreement for medications containing the active ingredient Teriparatide (ATC Code: H05AA02). The contract will be effective from December 1, 2025, to November 30, 2027, with the option for suppliers to enter into the contract a
464 days left to bid. Opened 8 months ago, deadline 27 Sept 2027.
This contract opportunity involves establishing a non-exclusive discount agreement for the medication Omalizumab (ATC Code: R03DX05) in Germany. The contract will be effective from December 1, 2024, to November 30, 2026, with the option for suppliers to enter into the contract at any time during thi
This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology
Adoption Counts is accepting applications for a therapy services framework that reopens every 4 months to ensure market competition and access to innovative support services.
Betsi Cadwaladr University Health Board is procuring pathology testing services for HFE gene analysis and extraction.
Powys Teaching Health Board seeks an experienced dental provider to deliver NHS General Dental Services in Llandrindod Wells.
UK Atomic Energy Authority seeks suppliers of Infrared Thermography Cameras for MAST-U diagnostic equipment; responses due 3 June 2026.
